tyloxapol has been researched along with dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hall, SB; Holm, BA; Notter, RH; Venkitaraman, AR; Whitsett, JA | 1 |
Antal, JM; Divis, LT; Thomassen, MJ; Wiedemann, HP | 1 |
Belik, J; Duncan, JE; Hatch, GM | 1 |
Baker, JR; Bielinska, AU; Chen, C; Eichman, J; Kukowska-Latallo, JF | 1 |
4 other study(ies) available for tyloxapol and dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination
Article | Year |
---|---|
Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adsorption; Albumins; Animals; Apoproteins; Biological Products; Cattle; Drug Combinations; Fatty Alcohols; In Vitro Techniques; Lung; Phosphorylcholine; Polyethylene Glycols; Proteolipids; Pulmonary Surfactants; Rats; Surface Tension; Surface-Active Agents | 1992 |
Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf.
Topics: Cells, Cultured; Cytokines; Down-Regulation; Drug Combinations; Fatty Alcohols; Humans; Macrophages, Alveolar; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; RNA, Messenger; Surface-Active Agents | 1995 |
Susceptibility of exogenous surfactant to phospholipase A2 degradation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetylation; Animals; Biological Products; Cattle; Chemistry, Pharmaceutical; Drug Combinations; Fatty Alcohols; Hydrogen-Ion Concentration; Lysophosphatidylcholines; Phospholipases A; Phospholipases A2; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants | 1996 |
Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro.
Topics: Animals; Bronchi; Cell Membrane Permeability; Drug Combinations; Endosomes; Endothelium, Vascular; Fatty Alcohols; Gene Expression; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; In Situ Hybridization; Jurkat Cells; Luciferases; Luminescent Proteins; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Surface-Active Agents; Swine; Transfection | 1999 |